Clinical efficacy of serum human epididymis protein 4 as a diagnostic biomarker of ovarian cancer: A pilot study.
about
The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses.Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women.Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer.The Establishment of an HE4-CLIA Method and the Combined Analysis of HE4 and CA125 in Ovarian Cancer.
P2860
Clinical efficacy of serum human epididymis protein 4 as a diagnostic biomarker of ovarian cancer: A pilot study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical efficacy of serum hum ...... ovarian cancer: A pilot study.
@en
Clinical efficacy of serum hum ...... ovarian cancer: A pilot study.
@nl
type
label
Clinical efficacy of serum hum ...... ovarian cancer: A pilot study.
@en
Clinical efficacy of serum hum ...... ovarian cancer: A pilot study.
@nl
prefLabel
Clinical efficacy of serum hum ...... ovarian cancer: A pilot study.
@en
Clinical efficacy of serum hum ...... ovarian cancer: A pilot study.
@nl
P2093
P2860
P921
P1476
Clinical efficacy of serum hum ...... ovarian cancer: A pilot study.
@en
P2093
Seung Cheol Kim
Shin Hye Chung
Soo Yoon Lee
P2860
P304
P356
10.5468/OGS.2013.56.4.234
P577
2013-07-15T00:00:00Z